Literature DB >> 18255301

Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration.

Karine Palin1, Colm Cunningham, Penny Forse, V Hugh Perry, Nick Platt.   

Abstract

Axon loss in the CNS is characteristic of many neurodegenerative diseases but the mechanisms of axon degeneration are poorly understood. In particular, we know little of the inflammatory response triggered by CNS axon degeneration with comparison to that provoked by death of the neuronal cell body. We show that Wallerian degeneration of the mouse optic nerve induces transcription of TGF-beta1 and TNF-alpha, but not pro-inflammatory cytokines IL-1beta and IL-6 and microglial activation. This atypical inflammatory response resembles macrophages that have phagocytosed apoptotic cells and prion-infected CNS. Significantly, peripheral endotoxin challenge after injury switched this profile by inducing IL-1beta, IL-6 transcripts, other inflammation-associated products and reducing neurofilament immunoreactivity. We propose that microglia are activated by Wallerian degeneration and persist in an atypical but "primed" state and can be switched by systemic inflammation to provoke a classical pro-inflammatory profile with potentially deleterious consequences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18255301     DOI: 10.1016/j.nbd.2007.11.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

Review 1.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

Review 4.  Immune activation in brain aging and neurodegeneration: too much or too little?

Authors:  Kurt M Lucin; Tony Wyss-Coray
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 5.  Microglia in neurodegenerative disease.

Authors:  V Hugh Perry; James A R Nicoll; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

6.  Integrin CD11b Deficiency Aggravates Retinal Microglial Activation and RGCs Degeneration After Acute Optic Nerve Injury.

Authors:  Xiao-Feng Cai; Sen Lin; Zhao Geng; Lin-Lin Luo; Yun-Jia Liu; Zhou Zhang; Wen-Yi Liu; Xi Chen; Xue Li; Jun Yan; Jian Ye
Journal:  Neurochem Res       Date:  2020-02-12       Impact factor: 3.996

7.  Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium.

Authors:  Robert H Field; Anna Gossen; Colm Cunningham
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

Review 8.  Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease.

Authors:  Diana M Norden; Megan M Muccigrosso; Jonathan P Godbout
Journal:  Neuropharmacology       Date:  2014-11-13       Impact factor: 5.250

9.  Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Authors:  Ashley M Fenn; John C Gensel; Yan Huang; Phillip G Popovich; Jonathan Lifshitz; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-10-25       Impact factor: 13.382

10.  Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.

Authors:  Monica G Ferrini; Istvan Kovanecz; Sandra Sanchez; Chiome Umeh; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2008-12-02       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.